References
Key articles
World Health Organization. Campylobacter fact sheet. 1 May 2020 [internet publication].Full text
Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80.Full text Abstract
Government of British Columbia. Laboratory. Nov 2023 [internet publication].Full text
Riddle MS, DuPont HL, Connor BA. ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol. 2016 May;111(5):602-22.Full text Abstract
World Gastroenterology Organisation (WGO). WGO practice guideline: acute diarrhea. 2012 [internet publication].Full text
Reference articles
1. Man SM. The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol. 2011 Oct 25;8(12):669-85. Abstract
2. Kaakoush NO, Castaño-Rodríguez N, Michell HM, Man SM. Global epidemiology of Campylobacter infection. Clin Microbiol Rev. 2015 Jul;28(3):687-720.Full text Abstract
3. Centers for Disease Control and Prevention. Food safety: campylobacter. 14 April 2021 [internet publication].Full text
4. Blaser MJ. Epidemiologic and clinical features of Campylobacter jejuni infections. J Infect Dis. 1997 Dec;176(suppl 2):S103-5.Full text Abstract
5. Fernández-Cruz A, Muñoz P, Mohedano R, et al. Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years. Medicine (Baltimore). 2010 Sep;89(5):319-30. Abstract
6. World Health Organization. Campylobacter fact sheet. 1 May 2020 [internet publication].Full text
7. Delahoy MJ, Shah HJ, Weller DL, et al. Preliminary incidence and trends of infections caused by pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2022. MMWR Morb Mortal Wkly Rep 2023;72:701-6.Full text
8. Public Health England (UK). Research and analysis: Campylobacter data 2010 to 2019. Apr 2024 [internet publication].Full text
9. European Food Safety Authority, European Centre for Disease Prevention and Control. The European union one health 2019 zoonoses report. EFSA J. 2021;19(2):6406, 286 pp.Full text
10. Centers for Disease Control and Prevention. Foodborne Diseases Active Surveillance Network (FoodNet): FoodNet data. Jun 2023 [internet publication].Full text
11. Skirrow MB. A demographic survey of campylobacter, salmonella, shigella infections in England: a public health laboratory service survey. Epidemiol Infect. 1987 Dec;99(3):647-57. Abstract
12. Green MS, Schwartz N, Peer V. Sex differences in campylobacteriosis incidence rates at different ages - a seven country, multi-year, meta-analysis. A potential mechanism for the infection. BMC Infect Dis. 2020 Aug 25;20(1):625.Full text Abstract
13. Kovats RS, Edwards SJ, Charron D, et al. Climate variability and campylobacter infection: an international study. Int J Biometeorol. 2005 Mar;49(4):207-14. Abstract
14. Centers for Disease Control and Prevention. CDC Yellow Book 2024: traveler's health. Section 5: travel-associated infections & diseases - campylobacteriosis. May 2023 [internet publication].Full text
15. Humphrey T, O’Brien S, Madsen M. Campylobacters as zoonotic pathogens: a food production perspective. Int J Food Microbiol. 2007 Jul 15;117(3):237-57. Abstract
16. Young KT, Davis LM, Dirita VJ. Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol. 2007 Sep;5(9):665-79. Abstract
17. Wagenaar JA, van Bergen MA, Blaser MJ, et al. Campylobacter fetus infections in humans: exposure and disease. Clin Infect Dis. 2014 Jun;58(11):1579-86.Full text Abstract
18. Domingues AR, Pires SM, Halasa T, et al. Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections. Epidemiol Infect. 2012 Jun;140(6):970-81.Full text Abstract
19. van Putten JP, van Alphen LB, Wösten MM, et al. Molecular mechanisms of campylobacter infection. Curr Top Microbiol Immunol. 2009;337:197-229. Abstract
20. Haddad N, Marce C, Magras C, et al. An overview of methods used to clarify pathogenesis mechanisms of Campylobacter jejuni. J Food Prot. 2010 Apr;73(4):786-802.Full text Abstract
21. Dasti JI, Tareen AM, Lugert R, et al. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol. 2010 Apr;300(4):205-11. Abstract
22. Kapperud G, Lassen J, Ostroff SM, et al. Clinical features of sporadic Campylobacter infections in Norway. Scand J Infect Dis. 1992;24(6):741-9. Abstract
23. Saeed AM, Harris NV, DiGiacomo RF. The role of exposure to animals in the etiology of Campylobacter jejuni/coli enteritis. Am J Epidemiol. 1993 Jan 1;137(1):108-14. Abstract
24. Doorduyn Y, Van Den Brandhof WE, Van Duynhoven YT, et al. Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in The Netherlands: a case-control study. Epidemiol Infect. 2010 Oct;138(10):1391-404. Abstract
25. Sorvillo FJ, Lieb LE, Waterman SH. Incidence of campylobacteriosis among patients with AIDS in Los Angeles County. J Acquir Immune Defic Syndr. 1991;4(6):598-602. Abstract
26. Guzman-Herrador B, Carlander A, Etelberg S, et al. Waterborne outbreaks in the Nordic countries, 1998 to 2012. Euro Surveill. 2015 Jun 18;20(24):21160.Full text Abstract
27. Hinnenkamp R, Sorenson S, Evanson E, et al. Notes from the field: campylobacteriosis outbreak associated with consumption of raw water - Montana, 2022. MMWR Morb Mortal Wkly Rep 2023;72:411-2.Full text
28. Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80.Full text Abstract
29. Tam CC, Higgins CD, Neal KR, et al; Campylobacter Case-Control Study Group. Chicken consumption and use of acid-suppressing medications as risk factors for Campylobacter enteritis, England. Emerg Infect Dis. 2009 Sep;15(9):1402-8.Full text Abstract
30. Ejemot-Nwadiaro RI, Ehiri JE, Arikpo D, et al. Hand-washing promotion for preventing diarrhoea. Cochrane Database Syst Rev. 2021 Jan 6;12(1):CD004265.Full text Abstract
31. Havelaar AH, van Pelt W, Ang CW et al. Immunity to Campylobacter: its role in risk assessment and epidemiology. Crit Rev Microbiol. 2009;35(1):1-22. Abstract
32. Same RG, Tamma PD. Campylobacter infections in children. Pediatr Rev. 2018 Nov;39(11):533-41.Full text Abstract
33. White AE, Ciampa N, Chen Y, et al. Characteristics of Campylobacter and salmonella infections and acute gastroenteritis in older adults in Australia, Canada, and the United States. Clin Infect Dis. 2019 Oct 15;69(9):1545-52.Full text Abstract
34. Tribble DR, Baqar S, Scott DA, et al. Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans. Infect Immun. 2010 Apr;78(4):1750-9.Full text Abstract
35. Cover TL, Perez-Perez GI, Blaser MJ. Evaluation of cytotoxic activity in fecal filtrates from patients with Campylobacter jejuni or Campylobacter coli enteritis. FEMS Microbiol Lett. 1990 Aug;58(3):301-4.Full text Abstract
36. Government of British Columbia. Infectious diarrhea - guideline for investigation. Dec 2023 [internet publication].Full text
37. Schmidt-Ott R, Schmidt H, Feldmann S, et al. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome. Clin Vaccine Immunol. 2006 Jul;13(7):779-83.Full text Abstract
38. O'Hara GA, Fitchett JRA, Klein JL. Campylobacter bacteremia in London: a 44-year single-center study. Diagn Microbiol Infect Dis. 2017 Sep;89(1):67-71. Abstract
39. Herbinger KH, Hanus I, Beissner M, et al. Lymphocytosis and lymphopenia induced by imported infectious diseases: a controlled cross-sectional study of 17,229 diseased German travelers returning from the tropics and subtropics. Am J Trop Med Hyg. 2016 Jun 1;94(6):1385-91.Full text Abstract
40. Government of British Columbia. Laboratory. Nov 2023 [internet publication].Full text
41. Riddle MS, DuPont HL, Connor BA. ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol. 2016 May;111(5):602-22.Full text Abstract
42. Gregorio GV, Gonzales ML, Dans LF, Martinez EG. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev. 2016 Dec 13;12(12):CD006519.Full text Abstract
43. Ternhag A, Asikainen T, Giesecke J, et al. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin Infect Dis. 2007 Mar 1;44(5):696-700. Abstract
44. World Gastroenterology Organisation (WGO). WGO practice guideline: acute diarrhea. 2012 [internet publication].Full text
45. Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3):804.Full text Abstract
46. Centers for Disease Control and Prevention. Antibiotic/antimicrobial resistance (AR/AMR). Nov 2021 [internet publication].Full text
47. Schiaffino F, Kosek MN. Intestinal and extra-intestinal manifestations of Campylobacter in the immunocompromised host. Curr Treat Options Infect Dis. 2020;12(4):361-74.
48. Roa-Bautista A, Brown LK, Tadros S, et al. Clinical features, immunological characteristics, and treatment outcomes of Campylobacter spp. infections in patients with common variable immunodeficiency. J Allergy Clin Immunol Pract. 2023 Nov;11(11):3493-501.e4.Full text Abstract
49. Collinson S, Deans A, Padua-Zamora A, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2020 Dec 8;12(12):CD003048.Full text Abstract
50. Pérez-Gaxiola G, Cuello-García CA, Florez ID, Pérez-Pico VM. Smectite for acute infectious diarrhoea in children. Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD011526.Full text Abstract
51. Hlashwayo DF, Barbosa F, Langa S, et al. A systematic review of in vitro activity of medicinal plants from sub-Saharan Africa against Campylobacter spp. Evid Based Complement Alternat Med. 2020 May 15;2020:9485364.Full text Abstract
52. Hessulf F, Ljungberg J, Johansson PA, et al. Campylobacter jejuni-associated perimyocarditis: two case reports and review of the literature. BMC Infect Dis. 2016 Jun 14;16:289.Full text Abstract
53. Peterson MC. Rheumatic manifestations of Campylobacter jejuni and C. fetus infections in adults. Scand J Rheumatol. 1994;23(4):167-70. Abstract
Use of this content is subject to our disclaimer